A University of Pennsylvania-led team found that genetic population structure in Africa is associated with geography, as well as with language and lifestyle.
In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.
The funding is being provided to a number of early-career investigators and collaborative research groups using genomics and other technologies.
The group aims to collect and sequence more than 2,500 blood samples by 2020 to improve primary diagnosis and treatment options for patients suffering from Parkinson's disease.
Researchers report on a case in which a CAR T-cell therapy was mistakenly delivered to a cancer cell, Stat News writes.
With RNA sequence, expression quantitative trait locus, genome-wide association, and other data, researchers identified disease-related genes in the kidney glomerulus and tubule compartments.
The researchers characterized how gene therapy affects the immune cell repertoires and microbiomes of X-linked severe combined immunodeficiency patients.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Plasmodium vivax parasites that infect humans have highly similar genomes to parasites that infect apes, a finding with possible disease-eradication consequences.
Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.